Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bile Acids: Physiological Activity and Perspectives of Using in Clinical and Laboratory Diagnostics. | Molecules | 2022 | 36431930 | PubTator, text mining | PubMed |
| The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity. | Int J Mol Sci | 2022 | 36430444 | PubTator, text mining | PubMed |
| Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update. | Cells | 2022 | 36428959 | PubTator, text mining | PubMed |
| The evaluation of serum lipid profile in chronic Hepatitis B patients at a Tertiary Care Centre in Western India: A cross-sectional study. | Ann Afr Med | 2022 | 36412329 | PubTator, text mining | PubMed |
| Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-κBp65/HK2 signalling. | J Exp Clin Cancer Res | 2022 | 36411480 | PubTator, text mining | PubMed |
| Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins. | Front Immunol | 2022 | 36405686 | PubTator, text mining | PubMed |
| Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles. | PLoS One | 2022 | 36383523 | PubTator, text mining | PubMed |
| Hepatitis B virus suppresses complement C9 synthesis by limiting the availability of transcription factor USF-1 and inhibits formation of membrane attack complex: implications in disease pathogenesis. | J Biomed Sci | 2022 | 36376872 | PubTator, text mining | PubMed |
| Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs. | Trends Pharmacol Sci | 2022 | 36374805 | PubTator, text mining | PubMed |
| Hepatitis B Virus X Protein Stimulates Hepatitis C Virus (HCV) Replication by Protecting HCV Core Protein from E6AP-Mediated Proteasomal Degradation. | Microbiol Spectr | 2022 | 36374094 | PubTator, text mining | PubMed |
| Ivermectin Inhibits HBV Entry into the Nucleus by Suppressing KPNA2. | Viruses | 2022 | 36366568 | PubTator, text mining | PubMed |
| Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies. | Viruses | 2022 | 36366502 | PubTator, text mining | PubMed |
| Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries. | Microorganisms | 2022 | 36363693 | PubTator, text mining | PubMed |
| Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease. | Life (Basel) | 2022 | 36362837 | PubTator, text mining | PubMed |
| The Etiology of Cholelithiasis in Children and Adolescents-A Literature Review. | Int J Mol Sci | 2022 | 36362164 | PubTator, text mining | PubMed |
| Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics. | Genes (Basel) | 2022 | 36360178 | PubTator, text mining | PubMed |
| Inflammatory signaling on cytochrome P450-mediated drug metabolism in hepatocytes. | Front Pharmacol | 2022 | 36353494 | PubTator, text mining | PubMed |
| Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment. | World J Gastroenterol | 2022 | 36353205 | PubTator, text mining | PubMed |
| Structure-based virtual screening and molecular dynamics of potential inhibitors targeting sodium-bile acid co-transporter of carcinogenic liver fluke Clonorchis sinensis. | PLoS Negl Trop Dis | 2022 | 36350897 | PubTator, text mining | PubMed |
| Downstream bioprocessing of human pluripotent stem cell-derived therapeutics. | Eng Life Sci | 2022 | 36348655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=32